MedReleaf Corp. (TSX:LEAF) (OTC: MEDFF) today announced that it has received certification under the European Medical Agency's Good Manufacturing Practices ("EU GMP") Standards for its Markham facility from authorities in Cologne, Germany to make a first export of its products into Germany and has completed its first shipment of medical cannabis to Cannamedical Pharma GmbH ("Cannamedical").
Read more
MedReleaf receives EU GMP certification for shipment from its Markham facility and completes first export to Cannamedical Pharma in Germany
